Pharmacogenomic Testing in Primary Care

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

September 5, 2021

Study Completion Date

May 6, 2022

Conditions
Antidepressants Causing Adverse Effects in Therapeutic Use
Interventions
DIAGNOSTIC_TEST

PGx test

A laboratory developed genetic test that differentiates common and uncommon alleles in genes that have been previously identified as being involved in either the metabolism or response of drugs used in the treatment of depression and/or anxiety. The results are provided as a report that contains information related to the allele status of the patient's genes, translates this into a phenotype, and relates this phenotype to recommendation classes for drugs.

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT03270891 - Pharmacogenomic Testing in Primary Care | Biotech Hunter | Biotech Hunter